Digital therapeutics and wellness is an innovative new class of medicine that gives participants access to the world's most effective behavior therapies, enhanced with smart technology, and delivered directly to their fingerprints or front door. Digital therapeutics and wellness include software and devices
Âé¶¹Ô´´ Analysis and Insights: Global Digital Therapeutics and Wellness Âé¶¹Ô´´
The global Digital Therapeutics and Wellness market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Digital Therapeutics and Wellness market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Digital Therapeutics and Wellness, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Digital Therapeutics and Wellness, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Digital Therapeutics and Wellness revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Digital Therapeutics and Wellness market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Digital Therapeutics and Wellness revenue, projected growth trends, production technology, application and end-user industry.
Âé¶¹Ô´´ Segmentation
By Company
Canary Health
Livongo (Teladoc Health)
Medtronic
2Morrow
Omada
Proteus
Pear Therapeutics
Propeller Health
WellDoc
Noom
My mHealth
Vida Health
Blue Mesa Health
Glytec (Aseko)
Ginger.io
Twine Health (Fitbit)
Big Health
Click Therapeutics
Quit Genius
Onlife Health
Mindstrong Health
Segment by Type
Software
Devices
Segment by Application
Cardiovascular Disease and Hypertension
Diabetes and Prediabetes
Obesity and Weight Loss
Smoking Cessation
Other Digital Therapeutics
Wellness
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Digital Therapeutics and Wellness in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Digital Therapeutics and Wellness companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Therapeutics and Wellness revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Âé¶¹Ô´´ Analysis by Type
1.2.1 Global Digital Therapeutics and Wellness Âé¶¹Ô´´ Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Software
1.2.3 Devices
1.3 Âé¶¹Ô´´ by Application
1.3.1 Global Digital Therapeutics and Wellness Âé¶¹Ô´´ Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Cardiovascular Disease and Hypertension
1.3.3 Diabetes and Prediabetes
1.3.4 Obesity and Weight Loss
1.3.5 Smoking Cessation
1.3.6 Other Digital Therapeutics
1.3.7 Wellness
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Digital Therapeutics and Wellness Âé¶¹Ô´´ Perspective (2019-2030)
2.2 Global Digital Therapeutics and Wellness Growth Trends by Region
2.2.1 Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
2.2.2 Digital Therapeutics and Wellness Historic Âé¶¹Ô´´ Size by Region (2019-2024)
2.2.3 Digital Therapeutics and Wellness Forecasted Âé¶¹Ô´´ Size by Region (2025-2030)
2.3 Digital Therapeutics and Wellness Âé¶¹Ô´´ Dynamics
2.3.1 Digital Therapeutics and Wellness Industry Trends
2.3.2 Digital Therapeutics and Wellness Âé¶¹Ô´´ Drivers
2.3.3 Digital Therapeutics and Wellness Âé¶¹Ô´´ Challenges
2.3.4 Digital Therapeutics and Wellness Âé¶¹Ô´´ Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Digital Therapeutics and Wellness by Players
3.1.1 Global Digital Therapeutics and Wellness Revenue by Players (2019-2024)
3.1.2 Global Digital Therapeutics and Wellness Revenue Âé¶¹Ô´´ Share by Players (2019-2024)
3.2 Global Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Digital Therapeutics and Wellness, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Digital Therapeutics and Wellness Âé¶¹Ô´´ Concentration Ratio
3.4.1 Global Digital Therapeutics and Wellness Âé¶¹Ô´´ Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Digital Therapeutics and Wellness Revenue in 2023
3.5 Global Key Players of Digital Therapeutics and Wellness Head office and Area Served
3.6 Global Key Players of Digital Therapeutics and Wellness, Product and Application
3.7 Global Key Players of Digital Therapeutics and Wellness, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Digital Therapeutics and Wellness Breakdown Data by Type
4.1 Global Digital Therapeutics and Wellness Historic Âé¶¹Ô´´ Size by Type (2019-2024)
4.2 Global Digital Therapeutics and Wellness Forecasted Âé¶¹Ô´´ Size by Type (2025-2030)
5 Digital Therapeutics and Wellness Breakdown Data by Application
5.1 Global Digital Therapeutics and Wellness Historic Âé¶¹Ô´´ Size by Application (2019-2024)
5.2 Global Digital Therapeutics and Wellness Forecasted Âé¶¹Ô´´ Size by Application (2025-2030)
6 North America
6.1 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size (2019-2030)
6.2 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type
6.2.1 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2019-2024)
6.2.2 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2025-2030)
6.2.3 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Type (2019-2030)
6.3 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application
6.3.1 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2019-2024)
6.3.2 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2025-2030)
6.3.3 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Application (2019-2030)
6.4 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country
6.4.1 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country (2019-2024)
6.4.3 North America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size (2019-2030)
7.2 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type
7.2.1 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2019-2024)
7.2.2 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2025-2030)
7.2.3 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Type (2019-2030)
7.3 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application
7.3.1 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2019-2024)
7.3.2 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2025-2030)
7.3.3 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Application (2019-2030)
7.4 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country
7.4.1 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country (2019-2024)
7.4.3 Europe Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size (2019-2030)
8.2 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type
8.2.1 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2019-2024)
8.2.2 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2025-2030)
8.2.3 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Type (2019-2030)
8.3 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application
8.3.1 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2019-2024)
8.3.2 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2025-2030)
8.3.3 China Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size (2019-2030)
9.2 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type
9.2.1 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2019-2024)
9.2.2 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2025-2030)
9.2.3 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Type (2019-2030)
9.3 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application
9.3.1 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2019-2024)
9.3.2 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2025-2030)
9.3.3 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Application (2019-2030)
9.4 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Region
9.4.1 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Region (2019-2024)
9.4.3 Asia Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size (2019-2030)
10.2 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type
10.2.1 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application
10.3.1 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country
10.4.1 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Digital Therapeutics and Wellness Âé¶¹Ô´´ Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Canary Health
11.1.1 Canary Health Company Details
11.1.2 Canary Health Business Overview
11.1.3 Canary Health Digital Therapeutics and Wellness Introduction
11.1.4 Canary Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.1.5 Canary Health Recent Developments
11.2 Livongo (Teladoc Health)
11.2.1 Livongo (Teladoc Health) Company Details
11.2.2 Livongo (Teladoc Health) Business Overview
11.2.3 Livongo (Teladoc Health) Digital Therapeutics and Wellness Introduction
11.2.4 Livongo (Teladoc Health) Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.2.5 Livongo (Teladoc Health) Recent Developments
11.3 Medtronic
11.3.1 Medtronic Company Details
11.3.2 Medtronic Business Overview
11.3.3 Medtronic Digital Therapeutics and Wellness Introduction
11.3.4 Medtronic Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.3.5 Medtronic Recent Developments
11.4 2Morrow
11.4.1 2Morrow Company Details
11.4.2 2Morrow Business Overview
11.4.3 2Morrow Digital Therapeutics and Wellness Introduction
11.4.4 2Morrow Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.4.5 2Morrow Recent Developments
11.5 Omada
11.5.1 Omada Company Details
11.5.2 Omada Business Overview
11.5.3 Omada Digital Therapeutics and Wellness Introduction
11.5.4 Omada Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.5.5 Omada Recent Developments
11.6 Proteus
11.6.1 Proteus Company Details
11.6.2 Proteus Business Overview
11.6.3 Proteus Digital Therapeutics and Wellness Introduction
11.6.4 Proteus Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.6.5 Proteus Recent Developments
11.7 Pear Therapeutics
11.7.1 Pear Therapeutics Company Details
11.7.2 Pear Therapeutics Business Overview
11.7.3 Pear Therapeutics Digital Therapeutics and Wellness Introduction
11.7.4 Pear Therapeutics Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.7.5 Pear Therapeutics Recent Developments
11.8 Propeller Health
11.8.1 Propeller Health Company Details
11.8.2 Propeller Health Business Overview
11.8.3 Propeller Health Digital Therapeutics and Wellness Introduction
11.8.4 Propeller Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.8.5 Propeller Health Recent Developments
11.9 WellDoc
11.9.1 WellDoc Company Details
11.9.2 WellDoc Business Overview
11.9.3 WellDoc Digital Therapeutics and Wellness Introduction
11.9.4 WellDoc Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.9.5 WellDoc Recent Developments
11.10 Noom
11.10.1 Noom Company Details
11.10.2 Noom Business Overview
11.10.3 Noom Digital Therapeutics and Wellness Introduction
11.10.4 Noom Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.10.5 Noom Recent Developments
11.11 My mHealth
11.11.1 My mHealth Company Details
11.11.2 My mHealth Business Overview
11.11.3 My mHealth Digital Therapeutics and Wellness Introduction
11.11.4 My mHealth Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.11.5 My mHealth Recent Developments
11.12 Vida Health
11.12.1 Vida Health Company Details
11.12.2 Vida Health Business Overview
11.12.3 Vida Health Digital Therapeutics and Wellness Introduction
11.12.4 Vida Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.12.5 Vida Health Recent Developments
11.13 Blue Mesa Health
11.13.1 Blue Mesa Health Company Details
11.13.2 Blue Mesa Health Business Overview
11.13.3 Blue Mesa Health Digital Therapeutics and Wellness Introduction
11.13.4 Blue Mesa Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.13.5 Blue Mesa Health Recent Developments
11.14 Glytec (Aseko)
11.14.1 Glytec (Aseko) Company Details
11.14.2 Glytec (Aseko) Business Overview
11.14.3 Glytec (Aseko) Digital Therapeutics and Wellness Introduction
11.14.4 Glytec (Aseko) Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.14.5 Glytec (Aseko) Recent Developments
11.15 Ginger.io
11.15.1 Ginger.io Company Details
11.15.2 Ginger.io Business Overview
11.15.3 Ginger.io Digital Therapeutics and Wellness Introduction
11.15.4 Ginger.io Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.15.5 Ginger.io Recent Developments
11.16 Twine Health (Fitbit)
11.16.1 Twine Health (Fitbit) Company Details
11.16.2 Twine Health (Fitbit) Business Overview
11.16.3 Twine Health (Fitbit) Digital Therapeutics and Wellness Introduction
11.16.4 Twine Health (Fitbit) Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.16.5 Twine Health (Fitbit) Recent Developments
11.17 Big Health
11.17.1 Big Health Company Details
11.17.2 Big Health Business Overview
11.17.3 Big Health Digital Therapeutics and Wellness Introduction
11.17.4 Big Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.17.5 Big Health Recent Developments
11.18 Click Therapeutics
11.18.1 Click Therapeutics Company Details
11.18.2 Click Therapeutics Business Overview
11.18.3 Click Therapeutics Digital Therapeutics and Wellness Introduction
11.18.4 Click Therapeutics Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.18.5 Click Therapeutics Recent Developments
11.19 Quit Genius
11.19.1 Quit Genius Company Details
11.19.2 Quit Genius Business Overview
11.19.3 Quit Genius Digital Therapeutics and Wellness Introduction
11.19.4 Quit Genius Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.19.5 Quit Genius Recent Developments
11.20 Onlife Health
11.20.1 Onlife Health Company Details
11.20.2 Onlife Health Business Overview
11.20.3 Onlife Health Digital Therapeutics and Wellness Introduction
11.20.4 Onlife Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.20.5 Onlife Health Recent Developments
11.21 Mindstrong Health
11.21.1 Mindstrong Health Company Details
11.21.2 Mindstrong Health Business Overview
11.21.3 Mindstrong Health Digital Therapeutics and Wellness Introduction
11.21.4 Mindstrong Health Revenue in Digital Therapeutics and Wellness Business (2019-2024)
11.21.5 Mindstrong Health Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Canary Health
Livongo (Teladoc Health)
Medtronic
2Morrow
Omada
Proteus
Pear Therapeutics
Propeller Health
WellDoc
Noom
My mHealth
Vida Health
Blue Mesa Health
Glytec (Aseko)
Ginger.io
Twine Health (Fitbit)
Big Health
Click Therapeutics
Quit Genius
Onlife Health
Mindstrong Health
Ìý
Ìý
*If Applicable.